EP
IPXL

Elkfork Partners’s Impax Laboratories, Inc. IPXL Stock Holding History

Elkfork Partners’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-8,426
Closed -$164K – 1053
2018
Q1 		$164K Buy
8,426
+132
+2% +$2.59K ﹤0.01% 842
2017
Q4 		$138K Buy
8,294
+1,826
+28% +$33.5K ﹤0.01% 875
2017
Q3 		$131K Buy
6,468
+506
+8% +$9.67K ﹤0.01% 840
2017
Q2 		$96K Buy
5,962
+2,728
+84% +$40.3K ﹤0.01% 871
2017
Q1 		$41K Buy
3,234
+550
+20% +$6.64K ﹤0.01% 940
2016
Q4 		$36K Buy
+2,684
New +$45.9K ﹤0.01% 927

Elkfork Partners's IPXL Position: Q2 2018 in Review

Elkfork Partners sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 8,426 shares — an estimated $164K sold.

Elkfork Partners first reported a position in IPXL in Q4 2016 and held it in 6 quarters. The position peaked at $164K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • Elkfork Partners reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • Elkfork Partners sold 8,426 Impax Laboratories, Inc. shares in Q2 2018, an estimated $164K.
  • Elkfork Partners first reported a position in Impax Laboratories, Inc. in Q4 2016 and held it in 6 quarters.
  • Elkfork Partners's Impax Laboratories, Inc. position peaked at $164K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Elkfork Partners's 13F filing for Q2 2018, filed 14 Aug 2018.